Cited by 71Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes

Open access
Khunti, Kamlesh, Alsifri, Saud, Aronson, Ronnie, Cigrovski Berković, Maja, Enters-Weijnen, Catherine, Forsén, Tom, Galstyan, Gagik, Geelhoed-Duijvestijn, Petronella +8 more·2017·Diabetes Research and Clinical Practice

Abstract

AIMS: Data on the impact of hypoglycaemia on patients' daily lives and diabetes self-management, particularly in developing countries, are lacking. The aim of this study was to assess fear of, and responses to, hypoglycaemia experienced by patients globally. MATERIALS AND METHODS: This non-interventional, multicentre, 4-week prospective study using self-assessment questionnaires and patient diaries consisted of 27,585 patients, ≥18years, with type 1 diabetes (n=8022) or type 2 diabetes (n=19,563) treated with insulin for >12months, at 2004 sites in 24 countries worldwide. RESULTS: Increased blood glucose monitoring (69.7%) and seeking medical assistance (62.0%) were the most common responses in the 4weeks following hypoglycaemic events for patients with type 1 diabetes and type 2 diabetes, respectively. Approximately 44% of patients with type 1 diabetes or type 2 diabetes increased calorie intake in response to a hypoglycaemic episode. Following hypoglycaemia, 3.9% (type 1 diabetes) and 6.2% (type 2 diabetes) of patients took leave from work or study. Regional differences in fear of, and responses to, hypoglycaemia were evident - in particular, a lower level of hypoglycaemic fear and utilisation of healthcare resources in Northern Europe and Canada. CONCLUSIONS: Hypoglycaemia has a major impact on patients and their behaviour. These global data for the first time reveal regional variations in response to hypoglycaemia and highlight the importance of patient education and management strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2017.05.004

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recurrent level 2 hypoglycemia and/or level 3 hypoglycemia is an urgent medical issue and requires intervention with medical treatment plan adjustment, behavioral intervention, and, in some cases, use of technology to assist with hypoglycemia prevention and identification.

    “Recurrent level 2 hypoglycemia and/or level 3 hypoglycemia is an urgent medical issue and requires intervention with medical treatment plan adjustment, behavioral intervention, and, in some cases, use of technology to assist with hypoglycemia prevention and identification (76,(79)(80)(81)(82).”
  • Some individuals with type 1 diabetes or type 2 diabetes and hypoglycemia who have a fear of hyperglycemia are resistant to relaxation of glycemic targets.

    “Conversely, some individuals with type 1 diabetes or type 2 diabetes and hypoglycemia who have a fear of hyperglycemia are resistant to relaxation of glycemic targets (74)(75)(76)(77)(78)(79)(80)(81)(82)(83).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., Kapur, R., Lalic, N., Ludvik, B., Moberg, E., Pedersen-Bjergaard, U., & Ramachandran, A.
Affiliations
  • University of Leicester (GB)
  • Armed Forces Hospital (SA)
  • LMC Diabetes & Endocrinology (Canada) (CA)
  • University Medical Center Utrecht (NL)
  • University of Helsinki (FI)
  • Sechenov University (RU)
  • Medisch Centrum Haaglanden (NL)
  • Technion – Israel Institute of Technology (IL)
  • Novo Nordisk (Denmark) (DK)
  • University of Belgrade (RS)
  • Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
  • Karolinska Institutet (SE)
  • India Diabetes Research Foundation (IN)
Corresponding author
  • Khunti, Kamlesh
  • Alsifri, Saud
  • Aronson, Ronnie
  • Enters-Weijnen, Catherine
  • Forsén, Tom
  • Galstyan, Gagik
  • Geelhoed-Duijvestijn, Petronella
  • Goldfracht, Margalit
  • Gydesen, Helge
  • Kapur, Rahul
  • Lalic, Nebojsa
  • Ludvik, Bernhard
  • Moberg, Erik
  • Ramachandran, Ambady
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2017-08
Volume
130
Pages
121-129
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2613962821
Cited by
71
References
32
Citations by year
2026: 1 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 5 · 2018: 10
FWCI
5.61
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • Figshare (submittedVersion, cc-by-nc-nd)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by-nc-nd)
Funders
  • Novo Nordisk A/S, Denmark
  • National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care – East Midlands
  • Leicester CIinical Trials Unit
  • NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
hypoglycemia, type 1 diabetes, type 2 diabetes, insulin-treated diabetes, patient-reported outcomes, fear of hypoglycemia, blood glucose monitoring, health care utilization, absenteeism, regional variation, patient education
MeSH terms
Patient Reported Outcome Measures, Self-Management, Adult, Canada, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Europe, Fear, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Education as Topic, Prospective Studies, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review